(Q39038799)

8 September 2017

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany (English)

1 reference

8 September 2017

Orthoebolavirus zairense

0 references

Germany

0 references

author

Jonas Schmidt-Chanasit

14

1 reference

8 September 2017

1

Stephan Günther

0 references

Heinz Feldmann

2

object named as

Heinz Feldmann

1 reference

8 September 2017

3

Thomas W Geisbert

1 reference

8 September 2017

6

Stuart T Nichol

1 reference

8 September 2017

10

Thomas G Ksiazek

1 reference

8 September 2017

5

Pierre E Rollin

1 reference

8 September 2017

9

Clarence J Peters

1 reference

8 September 2017

7

Ute Ströher

1 reference

8 September 2017

4

Lisa E Hensley

1 reference

8 September 2017

11

Stephan Becker

1 reference

8 September 2017

Harvey Artsob

8

1 reference

8 September 2017

Jan ter Meulen

12

1 reference

8 September 2017

Stephan Olschläger

13

1 reference

8 September 2017

Hinrich Sudeck

15

1 reference

8 September 2017

Gerd D Burchard

16

1 reference

8 September 2017

Stefan Schmiedel

17

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

Journal of Infectious Diseases

8 September 2017

1 reference

8 September 2017

204 Suppl 3

1 reference

8 September 2017

S785-90

1 reference

Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit

8 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Assessment of the risk of Ebola virus transmission from bodily fluids and fomites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

A case of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Effective post-exposure treatment of Ebola infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Postexposure treatment of Marburg virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Efficacy of Exogenous Interferon Treatment Initiated After Onset of Multiplication of Vesicular Stomatitis Virus in the Brains of Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Human asymptomatic Ebola infection and strong inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

Triage and management of accidental laboratory exposures to biosafety level-3 and -4 agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR298

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIR298

1 reference

8 September 2017

1 reference